Browsing by Author Caldwell, A S L

Jump to: 0-9 A B C D E F G H I J K L M N O P Q R S T U V W X Y Z
or enter first few letters:  
Showing results 1 to 3 of 3
Issue DateTitleAuthor(s)Citation
2014Characterization of Reproductive, Metabolic, and Endocrine Features of Polycystic Ovary Syndrome in Female Hyperandrogenic Mouse ModelsAllan, Charles; Caldwell, A S L; Desai, Reena; Handelsman, David; Jimenez, Mark; McMahon, Aisling; Middleton, Linda; Walters, Kirsty; Concord Clinical School: ANZAC Research Institute; Concord Clinical School: ANZAC Research Institute; Concord Clinical School: ANZAC Research Institute; Concord Clinical School: ANZAC Research Institute; Concord Clinical School: Medicine; Concord Clinical School: ANZAC Research Institute; Concord Clinical School: ANZAC Research Institute; Concord Clinical School: ANZAC Research InstituteCharacterization of Reproductive, Metabolic, and Endocrine Features of Polycystic Ovary Syndrome in Female Hyperandrogenic Mouse Models, Endocrinology, vol.155, 8, 2014,pp 3146-3159
2015Haplosufficient genomic androgen receptor signaling is adequate to protect female mice from induction of polycystic ovary syndrome features by prenatal hyperandrogenization.Allan, Charles; Caldwell, A S L; Desai, Reena; Eid, S; Handelsman, David; Jimenez, Mark; McMahon, Aisling; Walters, Kirsty; Kay, C; Smith, Jeremy; Concord Clinical School: ANZAC Research Institute; Concord Clinical School: ANZAC Research Institute; Concord Clinical School: ANZAC Research Institute; Concord Clinical School: ANZAC Research Institute; Concord Clinical School: ANZAC Research Institute; Concord Clinical School: Medicine; Concord Clinical School: ANZAC Research Institute; Concord Clinical School: ANZAC Research InstituteHaplosufficient genomic androgen receptor signaling is adequate to protect female mice from induction of polycystic ovary syndrome features by prenatal hyperandrogenization., Endocrinology, vol.156, 4, 2015,pp 1441-1452
2017Neuroendocrine androgen action is a key extraovarian mediator in the development of polycystic ovary syndromeCaldwell, A S L; Desai, Reena; Edwards, M; Handelsman, David; Jimenez, Mark; Walters, Kirsty; Gilchrist, R; Concord Clinical School: ANZAC Research Institute; Concord Clinical School: ANZAC Research Institute; Concord Clinical School: ANZAC Research Institute; Concord Clinical School: ANZAC Research Institute; Concord Clinical School: Medicine; Concord Clinical School: ANZAC Research InstituteNeuroendocrine androgen action is a key extraovarian mediator in the development of polycystic ovary syndrome, Proceedings of the National Academy of Sciences of the United States of America (PNAS), vol.114, 16, 2017,pp E3334-E3343